ERLINA PLUS XR 12.5/2.5/1000MG TAB

Erlina Plus XR 12.5/2.5/1000mg is a sustained-release combination tablet formulated to provide extended therapeutic benefits. This multi-component formulation combines three active ingredients in precise proportions to support comprehensive management. The extended-release mechanism ensures gradual, consistent delivery throughout the day, optimizing efficacy while maintaining patient compliance. Suitable for patients requiring combination therapy, this tablet delivers coordinated pharmaceutical action for sustained clinical outcomes.